FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2083480590> ?p ?o ?g. }

• W2083480590 endingPage "469" @default.
• W2083480590 startingPage "468" @default.
• W2083480590 abstract "Hot off the Press1 April 2014free access Toll-like receptors hit calcium Marina de Bernard Marina de Bernard Department of Biology, University of Padova, Padova, Italy Search for more papers by this author Rosario Rizzuto Rosario Rizzuto [email protected] Department of Biomedical Sciences, CNR Neuroscience Institute, University of Padova, Padova, Italy Search for more papers by this author Marina de Bernard Marina de Bernard Department of Biology, University of Padova, Padova, Italy Search for more papers by this author Rosario Rizzuto Rosario Rizzuto [email protected] Department of Biomedical Sciences, CNR Neuroscience Institute, University of Padova, Padova, Italy Search for more papers by this author Author Information Marina Bernard1 and Rosario Rizzuto2 1Department of Biology, University of Padova, Padova, Italy 2Department of Biomedical Sciences, CNR Neuroscience Institute, University of Padova, Padova, Italy EMBO Reports (2014)15:468-469https://doi.org/10.1002/embr.201438685 See also: Y Shintani et al (April 2014) PDFDownload PDF of article text and main figures. ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinked InMendeleyWechatReddit Figures & Info Mitochondrial Ca2+ uptake is a multifarious signal that controls both the activity of matrix dehydrogenases and the sensitivity to apoptotic and necrotic challenges. Recent evidence indicates that mitochondria also play a role in triggering inflammation, as mitochondrial DNA, when released by the cell, is an important damage-associated molecular pattern (DAMP). Now, Toll-like receptors (TLRs) are shown to close the loop, by affecting in turn mitochondrial activity. Two studies by Shintani and colleagues, one in this issue of EMBO reports 12, identify a new TLR transduction mechanism that impinges directly on mitochondrial function. Upon binding of CpG oligodeoxynucleotides, TLR9—which in non-immune cells is retained in the ER—inhibits SERCA2, thus reducing Ca2+ transfer to the mitochondria and aerobic metabolism. A few years ago, putting together inflammation and mitochondrial Ca2+ handling would have been quite a bizarre idea. The complex signaling network downstream of cytokine receptors was accepted to lead to the nucleus and minimally affect mitochondria. In addition, during inflammatory responses, more attention was placed on oxygen consumption by NADPH oxidases than on the housekeeping machinery of aerobic respiration. Then, some surprising, novel information gradually set the stage for the heterodox association. Indeed, Ca2+ accumulation by energized mitochondria, an old notion of bioenergetics, has entered a glittering phase. Numerous examples now highlight the notion that cellular Ca2+ signals, evoked by a variety of physiological or pathological challenges, are decoded within mitochondria into effects as diverse as increased ATP production, release of apoptotic cofactors or bioenergetic collapse in necrosis. Moreover, altered mitochondrial Ca2+ handling plays a role in the pathogenesis of a variety of human diseases, ranging from neurodegenerative and metabolic disorders to cancer 3. Then, mitochondria directly stepped into the mechanisms of inflammation, as they were shown not only to be a target of toxic and/or immune damage, but also to directly promote the initiation and/or potentiation of inflammatory reactions by triggering TLR signaling. TLRs are a family of receptors, initially identified in immune cells, that includes 10 and 12 paralogues in humans and mice, respectively. Upon binding of specific ligands of bacterial, viral or fungal source (pathogen-associated molecular patterns, PAMPs), a signaling cascade is activated that culminates in the transcription of genes for inflammatory mediators, such as TNF-α and IL-6. In addition to microbial PAMPs, TLRs can also sense endogenous molecules released from infected or stressed cells (DAMPs). These ligands include nuclear structural components (such as HMG-B1), heat-shock proteins (HSP60 and HSP70) and also components of mitochondria (such as mtDNA) 4. The latter is released extracellularly upon tissue damage and is rich in unmethylated CpGs. Finally, the paradigm that TLRs are invariably associated with pro-inflammatory effects has been recently amended by the evidence that small doses of PAMPs may result in an attenuated inflammatory response to subsequent larger doses of PAMPs or to injury. This phenomenon is thought to be due to the transcription of genes coding for inhibitors of the TLR-NFκB signaling pathway 5. Moreover, evidence that TLRs are not exclusively expressed in immune cells but also in several other types of cells, including neurons and cardiomyocytes 5, suggested that this anti-inflammatory mechanism might operate directly on the potential targets of the inflammatory damage. Among the TLR ligands able to trigger an anti-inflammatory response, unmethylated CpG-oligodeoxynucleotide (CpG-ODN) ligands of TLR-9 were shown to be very potent. Indeed, their administration, which is well tolerated clinically, attenuates the acute inflammatory cardiac dysfunction induced by both LPS and ischemia–reperfusion, by inhibiting the NFκB pathway in ventricular myocytes 6. …altered mitochondrial Ca2+ handling plays a role in the pathogenesis of a variety of human diseases, ranging from neurodegenerative and metabolic disorders to cancer Shintani and colleagues identify an alternative TLR9 signaling pathway that, in addition to the canonical TLR-NFκB axis, accounts for the activation of an anti-inflammatory mechanism within the parenchymal cells of an inflamed tissue 12. The alternative route stems from a different intracellular sorting of TLR9 in immune and non-immune cells. In immune cells, the chaperone Unc93b1 shuttles TLR9 from the ER to the endo/lysosomal compartment, where processing of the receptor and binding to CpG-ODN initiates the canonical MyD88-dependent pro-inflammatory signaling pathway 7. In neurons or cardiomyocytes, which are at high risk of permanent damage by inflammation due to their poor regenerative capacity, Unc93b1 is expressed at low levels 8, and TLR9 is mainly retained in the ER 1. There, the engagement by CpG-ODN triggers a different, hitherto unknown signaling route 2. Through biochemical studies, Shintani and colleagues identify SERCA2 (isoform 2 of the sarco-endoplasmic reticulum Ca2+ ATPase) as a protein directly interacting with TLR9. They show that in cardiomyocytes (but not in cardiac fibroblasts), upon interaction with CpG-ODN, TLR9 binds the Ca2+ pump, reducing its activity and lowering [Ca2+] in the ER lumen. As to the downstream consequences, the authors appropriately draw their attention to the emerging link between mitochondrial [Ca2+] and pro-survival mechanisms, such as autophagy. Genetic ablation of the inositol 1,4,5 trisphosphate receptor (IP3R), which is the Ca2+ release channel of the ER, was previously shown to dramatically increase autophagic rates by impairing Ca2+ transfer to mitochondria and Ca2+-dependent stimulation of aerobic metabolism. Hence, ATP levels were decreased and AMPK signaling to autophagy stimulated 9. Accordingly, Shintani et al 12 also observe decreased mitochondrial [Ca2+] levels and ATP production, as well as increased AMPK signaling, in DAMP-challenged cells (Fig 1). Figure 1. Effect of TLR9 on mitochondrial Ca2+ signaling in non-immune cells(A) In the absence of TLR9 engagement, Ca2+ transfer from the ER to mitochondria stimulates the Ca2+-sensitive matrix dehydrogenases (DH) of the Krebs cycle, thus increasing electron feeding to the respiratory chain and ATP production. The increase in the ATP/AMP ratio decreases AMPK activity and suppresses autophagy. In addition, matrix [Ca2+] favors the opening of the permeability transition pore (PTP), thus triggering the mitochondrial morphological and functional alterations that occur in apoptosis and necrosis. (B) Upon engagement by CpG-ODN, TLR9 binds to SERCA2 and inhibits its activity, thus reducing both DH stimulation (and hence autophagy suppression) and sensitivity to apoptotic/necrotic challenges. Download figure Download PowerPoint Although the authors did not directly address this issue, decreased mitochondrial [Ca2+] loading is expected to correlate with lower sensitivity to apoptotic and necrotic challenges, thereby increasing cell resistance in the inflamed area. Indeed, numerous examples of pathology-related changes of mitochondrial Ca2+ homeostasis are available and provide a coherent picture 2. Oncogenes reduce ER Ca2+ levels and cancer-related miRNAs reduce the expression of the mitochondrial Ca2+ uniporter, thus reducing sensitivity to apoptosis, whereas tumor suppressor genes and viral proteins have the opposite effect. Thus, the observation that TLR9 protects parenchymal cells from death, operating through a different component of the Ca2+ signaling machinery, is an important addition to a well-established conceptual framework. The involvement of mitochondrial function as target of TLR activity, however, also opens the possibility that other processes—different from ATP production but still strictly dependent on mitochondrial bioenergetics—are involved in signal transduction. In particular, increased feeding of electrons to the respiratory chain due to the stimulation of Ca2+-dependent matrix dehydrogenases is expected to increase the production of ROS. Interestingly, the latter are known to contribute to the stabilization of HIF-1, a transcription factor that activates the expression of a number of genes involved in the adaptation of tissues to hypoxia 10. A reduction of mitochondrial Ca2+ loading should be paralleled by a decrease in ROS-dependent signaling. Thus, the cellular effects downstream of mitochondrial involvement could be very complex and include both rapid changes in sensitivity to cell death pathways and a global change of the proteomic profile and would be worth analyzing in detail. Overall, the papers by Shintani and colleagues tie together the role of mitochondria in the initiation of inflammation and in the regulation of cell sensitivity to the inflammatory environment, by placing the focus on the Ca2+-mediated signaling liaison between the ER and the mitochondria. It is tempting to speculate that the recent explosive advance in the molecular understanding of mitochondrial Ca2+ transport 2 will allow not only to rapidly expand these novel concepts, but also to develop new therapeutic approaches in the broad area of inflammatory diseases. Conflict of interest The authors declare that they have no conflict of interest. References Shintani Y, Kapoor A, Kaneko M et al (2013) Proc Natl Acad Sci USA 110: 5109–5114CrossrefCASPubMedWeb of Science®Google Scholar Shintani Y, Drexler HC, Kioka H et al (2014) EMBO Rep 15: 438–445Wiley Online LibraryCASPubMedWeb of Science®Google Scholar Rizzuto R, De Stefani D, Raffaello A et al (2012) Nat Rev Mol Cell Biol 13: 566–578CrossrefCASPubMedWeb of Science®Google Scholar Zhang Q, Raoof M, Chen Y et al (2010) Nature 464: 104–107CrossrefCASPubMedWeb of Science®Google Scholar Boyd JH (2012) Curr Infect Dis Rep 14: 455–461CrossrefPubMedWeb of Science®Google Scholar Mathur S (2011) Shock 36: 478–483CrossrefCASPubMedWeb of Science®Google Scholar Kim YM, Brinkmann MM, Paquet ME et al (2008) Nature 452: 234–238CrossrefCASPubMedWeb of Science®Google Scholar Ramaiah SK, Günthner R, Lech M et al (2013) Int J Mol Sci 14: 13213–13230CrossrefCASWeb of Science®Google Scholar Cárdenas C, Miller RA, Smith I et al (2010) Cell 142: 270–283CrossrefCASPubMedWeb of Science®Google Scholar Zepeda AB, Pessoa A, Castillo RL et al (2013) Cell Biochem Funct 31: 451–459Wiley Online LibraryCASPubMedWeb of Science®Google Scholar Previous ArticleNext Article Read MoreAbout the coverClose modalView large imageVolume 15,Issue 5,May 2014Cover picture: Inspired by the Scientific Report p 529. PET-CT image provided by the authors. Illustration by Laura Symul. Volume 15Issue 51 May 2014In this issue FiguresReferencesRelatedDetailsLoading ..." @default.
• W2083480590 created "2016-06-24" @default.
• W2083480590 creator A5006443780 @default.
• W2083480590 creator A5027748782 @default.
• W2083480590 date "2014-04-01" @default.
• W2083480590 modified "2023-10-14" @default.
• W2083480590 title "Toll‐like receptors hit calcium" @default.
• W2083480590 cites W1500739443 @default.
• W2083480590 cites W1969709153 @default.
• W2083480590 cites W1979167640 @default.
• W2083480590 cites W2025237130 @default.
• W2083480590 cites W2045288098 @default.
• W2083480590 cites W2061203855 @default.
• W2083480590 cites W2115021528 @default.
• W2083480590 cites W2122693759 @default.
• W2083480590 cites W2127046675 @default.
• W2083480590 cites W2134219545 @default.
• W2083480590 doi "https://doi.org/10.1002/embr.201438685" @default.
• W2083480590 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4210096" @default.
• W2083480590 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24692506" @default.
• W2083480590 hasPublicationYear "2014" @default.
• W2083480590 type Work @default.
• W2083480590 sameAs 2083480590 @default.
• W2083480590 citedByCount "5" @default.
• W2083480590 countsByYear W20834805902015 @default.
• W2083480590 countsByYear W20834805902017 @default.
• W2083480590 countsByYear W20834805902018 @default.
• W2083480590 countsByYear W20834805902021 @default.
• W2083480590 crossrefType "journal-article" @default.
• W2083480590 hasAuthorship W2083480590A5006443780 @default.
• W2083480590 hasAuthorship W2083480590A5027748782 @default.
• W2083480590 hasBestOaLocation W20834805902 @default.
• W2083480590 hasConcept C144133560 @default.
• W2083480590 hasConcept C170493617 @default.
• W2083480590 hasConcept C178790620 @default.
• W2083480590 hasConcept C185592680 @default.
• W2083480590 hasConcept C203014093 @default.
• W2083480590 hasConcept C2778025104 @default.
• W2083480590 hasConcept C519063684 @default.
• W2083480590 hasConcept C55493867 @default.
• W2083480590 hasConcept C70721500 @default.
• W2083480590 hasConcept C86803240 @default.
• W2083480590 hasConcept C95444343 @default.
• W2083480590 hasConceptScore W2083480590C144133560 @default.
• W2083480590 hasConceptScore W2083480590C170493617 @default.
• W2083480590 hasConceptScore W2083480590C178790620 @default.
• W2083480590 hasConceptScore W2083480590C185592680 @default.
• W2083480590 hasConceptScore W2083480590C203014093 @default.
• W2083480590 hasConceptScore W2083480590C2778025104 @default.
• W2083480590 hasConceptScore W2083480590C519063684 @default.
• W2083480590 hasConceptScore W2083480590C55493867 @default.
• W2083480590 hasConceptScore W2083480590C70721500 @default.
• W2083480590 hasConceptScore W2083480590C86803240 @default.
• W2083480590 hasConceptScore W2083480590C95444343 @default.
• W2083480590 hasIssue "5" @default.
• W2083480590 hasLocation W20834805901 @default.
• W2083480590 hasLocation W20834805902 @default.
• W2083480590 hasLocation W20834805903 @default.
• W2083480590 hasOpenAccess W2083480590 @default.
• W2083480590 hasPrimaryLocation W20834805901 @default.
• W2083480590 hasRelatedWork W1967636949 @default.
• W2083480590 hasRelatedWork W1982297066 @default.
• W2083480590 hasRelatedWork W2041645124 @default.
• W2083480590 hasRelatedWork W2366655330 @default.
• W2083480590 hasRelatedWork W2390841997 @default.
• W2083480590 hasRelatedWork W2408860080 @default.
• W2083480590 hasRelatedWork W2419298600 @default.
• W2083480590 hasRelatedWork W3093710889 @default.
• W2083480590 hasRelatedWork W3149127145 @default.
• W2083480590 hasRelatedWork W3161574264 @default.
• W2083480590 hasVolume "15" @default.
• W2083480590 isParatext "false" @default.
• W2083480590 isRetracted "false" @default.
• W2083480590 magId "2083480590" @default.
• W2083480590 workType "article" @default.